outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,21498.263095,3000.094448,154053.58869,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1935,703,0.2173277732,0.0585332101,0.8069156108,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2317,1412,1.4852791384,0.7471933735,2.9524540731,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,0.2753572246,0.03085496,2.4573553501,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1935,2640,0.3679859643,0.1204703836,1.1240411618,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2317,4271,1.1136665167,0.7122178893,1.7413956165,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,14485.227091,2010.5211333,104361.89922,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1935,703,0.1595292272,0.0340152054,0.7481822928,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2317,1412,1.6968228181,0.7877265834,3.655085072,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,0.2339955596,0.0260565593,2.101348887,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1935,2640,0.2474883788,0.0618639662,0.9900835879,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2317,4271,1.2071025938,0.6885226751,2.1162653384,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,15294.090413,2102.7257849,111240.94413,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1935,703,0.1744950303,0.0370252124,0.8223724755,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2317,1412,2.0499634076,0.9187296281,4.5740877878,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,0.2317763661,0.0257491503,2.0862934587,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1935,2640,0.2407177397,0.0600010183,0.9657341133,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2317,4271,1.1846798017,0.6613648253,2.1220757123,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,14640.582956,2027.7418364,105707.08038,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1935,703,0.1480711363,0.0316391919,0.6929715985,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2317,1412,1.5604204543,0.7322858027,3.3250842569,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,0.2282003981,0.0254049109,2.0498171359,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1935,2640,0.2477074857,0.0618838893,0.9915181346,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2317,4271,1.2105770664,0.6911979033,2.1202275453,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,14435.577608,2003.2885135,104021.91171,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1935,703,0.1582409703,0.0337611367,0.7416872509,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2317,1412,1.6507847089,0.7707840697,3.535478044,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,0.2345043308,0.0261128296,2.1059487628,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1935,2640,0.2496116309,0.0623903028,0.9986482431,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2317,4271,1.1958093631,0.6836919387,2.0915268296,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,15203.0326,2074.6064603,111410.14195,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1935,703,0.1626168833,0.0345726845,0.7648885577,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2317,1412,1.8570705626,0.8394230601,4.1084302284,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,0.2229327605,0.0247707365,2.0063600343,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1935,2640,0.2445486672,0.0609781986,0.98074479,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2317,4271,1.1744957809,0.6614466902,2.085489821,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,0.9601009698,0.2105689084,4.3776352311,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.4096071539,0.1887764928,0.8887654287,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2325,1428,0.9245349374,0.6602440218,1.2946195987,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1.0824639785,0.451156657,2.5971649684,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.8325768416,0.4377157099,1.5836402063,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2325,4313,0.7752835771,0.6186418712,0.971587364,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,1.3132905972,0.2665520005,6.4705280371,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.3843340402,0.1488054131,0.9926564589,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2325,1428,1.2364335526,0.8337787779,1.8335414268,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1.8387860972,0.6986703311,4.8393844148,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.9069160218,0.3988270446,2.0622891093,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2325,4313,1.0378275457,0.7690361547,1.4005661607,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,1.4291635132,0.2905987833,7.0286197484,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1936,705,0.4091897771,0.1581410518,1.0587780451,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2325,1428,1.31856081,0.8936738888,1.9454553069,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,1.8025166902,0.6843365083,4.7477613416,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.8960711012,0.3931341885,2.0424156482,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.0172981701,0.7516941851,1.376750795,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,1.3139068335,0.2668916335,6.4683600015,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1936,705,0.3575767891,0.1389809019,0.9199908644,1,1
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2325,1428,1.1392431795,0.7684257593,1.6890050944,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,1.7957966805,0.6817909493,4.7300213076,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.9099856768,0.4005699013,2.0672395238,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.042960483,0.7727182865,1.4077142835,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,1.3179926943,0.2675020831,6.4937989347,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1936,705,0.3860560654,0.1489295988,1.0007365012,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2325,1428,1.2508453647,0.8469355939,1.8473826554,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,1.8367701736,0.6978802671,4.8342456864,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.9031857413,0.3994412827,2.0422137588,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.0421774439,0.7738789039,1.4034932586,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,1.4575175345,0.2967687457,7.1582920848,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1936,705,0.3882068046,0.1502194229,1.0032292781,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2325,1428,1.2330018438,0.8394454472,1.8110689049,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,1.7511242684,0.664130581,4.6172187991,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.9001694573,0.3974561798,2.0387280233,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2325,4313,1.0287713857,0.7622602038,1.3884636227,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,550,126,0.6559045841,0.1818330593,2.365965931,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1912,679,0.6455125377,0.3531662697,1.1798590978,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2233,1337,0.6945021926,0.534425235,0.9025271711,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,550,636,0.3727340695,0.1823047736,0.762079258,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1912,2610,0.5969710922,0.4005874725,0.8896296301,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2233,4146,0.5698358344,0.4696348956,0.6914155682,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,550,126,0.752224898,0.196333801,2.8820421864,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1912,679,0.8856215792,0.4446022685,1.7641061175,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2233,1337,0.8708023892,0.6427575747,1.1797555266,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,550,636,0.3650929543,0.1661061853,0.8024557603,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1912,2610,0.8057816043,0.4859249112,1.3361817409,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2233,4146,0.7181652612,0.5610816423,0.9192269065,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,550,126,0.773734384,0.2008220407,2.9810716732,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1912,679,0.8984370957,0.4509535181,1.7899610104,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2233,1337,0.8998425621,0.660803973,1.2253507388,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,550,636,0.3656644942,0.1662813867,0.8041220068,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1912,2610,0.8041563735,0.4840410206,1.3359765921,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2233,4146,0.71407783,0.5574198949,0.9147630934,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,550,126,0.7552680737,0.196893438,2.8971501986,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1912,679,0.8457306718,0.4254875584,1.6810370952,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2233,1337,0.8255282034,0.6080986865,1.120701014,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,550,636,0.3592562427,0.1634827548,0.7894719422,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1912,2610,0.8096850426,0.4884951516,1.3420601332,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2233,4146,0.7199247128,0.5625600743,0.9213088802,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,550,126,0.7448040408,0.1943764208,2.8539112757,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1912,679,0.87642291,0.4403328901,1.7444009623,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2233,1337,0.8462263445,0.6230655049,1.149315795,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,550,636,0.3659213457,0.1664776813,0.8043025961,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1912,2610,0.8109682549,0.4890581085,1.3447676239,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2233,4146,0.7128833469,0.5566272866,0.9130035098,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,550,126,0.7843398371,0.2028640322,3.032518743,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1912,679,0.8578984681,0.4317749087,1.7045682062,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2233,1337,0.8333363665,0.6082753781,1.141669587,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,550,636,0.3591373665,0.1633434737,0.7896222915,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1912,2610,0.811835139,0.48899973,1.3478050241,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2233,4146,0.7093104974,0.5537090411,0.9086385526,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,553,128,0.9789384099,0.1145237449,8.3678752515,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1924,700,0.5829959614,0.2218662857,1.5319330287,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2269,1378,1.0141634259,0.7180939976,1.4323019797,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,553,641,0.4900662608,0.1702642638,1.4105422632,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1924,2635,0.7764531489,0.3864060687,1.560222629,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2269,4235,0.7239519384,0.5700441146,0.9194137712,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,553,128,3.6024519048,0.3909789749,33.192730449,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1924,700,0.4879554367,0.1516175656,1.5704018679,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,2269,1378,1.4594043451,0.9843616252,2.163697759,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,553,641,1.7169433913,0.5094712961,5.7861838962,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1924,2635,0.721941071,0.3052679055,1.707349186,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2269,4235,1.0467102349,0.7721157026,1.418961319,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,553,128,3.8709853675,0.4182046705,35.830608251,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1924,700,0.5110547009,0.1581190135,1.6517742012,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2269,1378,1.5797966465,1.047352591,2.3829200078,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,553,641,1.7143200466,0.5063612769,5.8039454362,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1924,2635,0.720119347,0.303992815,1.7058688506,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2269,4235,1.0263280881,0.7594203094,1.3870439483,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,553,128,3.6044763157,0.3913194416,33.201134746,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1924,700,0.4791107747,0.1489717946,1.5408764797,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2269,1378,1.4265401496,0.9570573737,2.126326858,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,553,641,1.702365662,0.5039975378,5.7501250095,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1924,2635,0.7224440845,0.3055285959,1.708270395,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2269,4235,1.047006348,0.7724387652,1.4191704795,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,553,128,3.6204526342,0.3929365481,33.358254252,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1924,700,0.4902390804,0.1522721686,1.5783209638,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2269,1378,1.4829875331,0.9939994652,2.2125283768,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,553,641,1.7146040711,0.5087289379,5.7788478339,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1924,2635,0.7182194172,0.3033885891,1.7002588423,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2269,4235,1.0523272938,0.774975644,1.4289387566,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,553,128,3.9059576308,0.4224001831,36.118604171,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1924,700,0.5045083988,0.1561356457,1.6301769101,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2269,1378,1.5602845689,1.0210996359,2.3841825522,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,553,641,1.6957028657,0.4995370365,5.7561461885,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1924,2635,0.7183441234,0.3031465279,1.7022074545,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2269,4235,1.0316542804,0.7627919824,1.3952828278,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,12457.62061,3085.5160021,50297.036592,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1926,699,1.1969534971,0.4053367189,3.53458645,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2281,1391,0.7269048641,0.5184369449,1.0191995125,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,0.2694442801,0.0574715787,1.2632369202,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1926,2636,0.6597330963,0.3710964452,1.1728696514,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2281,4237,0.6098441818,0.4738069688,0.7849397552,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,7210.1142163,1752.8610028,29657.655073,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1926,699,2.5673515021,0.7458616786,8.8371529531,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,2281,1391,0.8659302836,0.5885060311,1.2741335118,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,0.1808929267,0.0367727243,0.8898511465,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1926,2636,1.4292969995,0.6478133579,3.1535161908,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2281,4237,0.7194444762,0.5244485687,0.9869420668,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,7645.2659775,1848.6620413,31617.510698,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1926,699,2.6736705916,0.7834939948,9.1238917974,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2281,1391,0.9188414603,0.6183197882,1.3654255373,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,0.1788248144,0.0363733174,0.8791695814,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1926,2636,1.4121793888,0.6367132375,3.1321017197,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2281,4237,0.7106702012,0.5192509619,0.9726551743,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,7247.3726034,1757.7675312,29881.317478,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1926,699,2.4580348786,0.7095545989,8.5151100051,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2281,1391,0.8245862767,0.5571452081,1.2204045154,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,0.177979636,0.0361316228,0.8767043488,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1926,2636,1.4306014736,0.6484438584,3.1562031929,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2281,4237,0.7210587012,0.5257759767,0.9888729678,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,7473.3994209,1817.1333885,30736.157984,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1926,699,2.6077054478,0.754749847,9.0097768548,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2281,1391,0.9052981444,0.6120123598,1.3391310111,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,0.1801750206,0.0366246012,0.8863724641,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1926,2636,1.407285201,0.646533838,3.0631832713,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2281,4237,0.7307731506,0.5321066117,1.0036135353,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,7983.64972,1927.3602467,33070.445944,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1926,699,2.6339540922,0.7623156568,9.1008417557,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2281,1391,0.91143931,0.6094179895,1.3631393071,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,0.175056413,0.0355615494,0.8617382615,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1926,2636,1.3968354951,0.6382190375,3.0571783129,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2281,4237,0.7244134803,0.5283780374,0.9931807404,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,404846.44046,128526.4405,1275228.9702,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1933,704,1.2878829636,0.1503718172,11.030275212,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2312,1413,0.7028899115,0.4314622239,1.1450694878,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,398810.35036,128569.81054,1237068.7558,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1933,2640,0.8190382326,0.2601960747,2.5781466044,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2312,4291,0.6692614659,0.4606856697,0.9722701166,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,940409.80978,293930.5089,3008774.4673,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1933,704,1.5027209957,0.1648815797,13.695710554,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,2312,1413,0.8693806201,0.4796662075,1.575726309,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,923027.74233,291022.33247,2927542.3844,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1933,2640,0.7477291371,0.2085026407,2.6814953555,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2312,4291,0.8600746136,0.5171182978,1.4304818533,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,1072919.9505,332010.92789,3467226.8997,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1933,704,1.613604649,0.1756757013,14.821173016,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2312,1413,0.9824901859,0.5367568955,1.7983690073,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,980958.15137,307967.75707,3124609.225,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1933,2640,0.7328071849,0.2045870779,2.6248303449,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2312,4291,0.8389450693,0.5005800185,1.4060266157,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,944026.65263,293666.91744,3034684.0858,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1933,704,1.4493713177,0.1592675424,13.189612802,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2312,1413,0.8325643155,0.4496430597,1.5415857634,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,913488.98138,285682.42445,2920943.1441,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1933,2640,0.7479396912,0.2086293267,2.6813765377,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2312,4291,0.8602364919,0.5173373124,1.430414556,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,948975.75656,296704.74292,3035189.0491,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1933,704,1.5123385654,0.1659175887,13.784963696,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2312,1413,0.8860937349,0.493648379,1.5905290901,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,926179.55463,292012.25712,2937577.2643,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1933,2640,0.7429706262,0.2070593534,2.6659281136,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2312,4291,0.8654080629,0.5224501559,1.4334977354,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,1088257.0135,335987.57119,3524842.6699,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1933,704,1.5835957404,0.1724642043,14.540846197,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2312,1413,0.9549776607,0.5179999758,1.7605837357,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,978340.6466,304644.65348,3141858.5878,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1933,2640,0.73199588,0.2043564107,2.6219777813,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2312,4291,0.8446448127,0.5075058608,1.4057470361,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,3.8914288582,0.5260259774,28.787967152,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.903051423,0.6310444361,1.2923049883,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2325,1428,0.8462476637,0.7296620621,0.9814613442,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1.4536135569,0.7453782038,2.8347922734,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.1551484042,0.9118898639,1.4632993396,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2325,4313,0.8950919656,0.8029055624,0.9978628427,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,8.9290042965,1.1677638033,68.27332505,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1936,705,1.092213376,0.6966543967,1.712369956,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,2325,1428,0.8889692145,0.7488324515,1.0553312197,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,2.4893223481,1.0689123061,5.7972255699,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.404194703,1.0015779234,1.9686563749,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2325,4313,0.9703930196,0.8461283272,1.1129075605,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,9.7719867561,1.2780149338,74.718786638,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1936,705,1.1669874301,0.7435808106,1.8314884442,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2325,1428,0.9721910955,0.818649035,1.154530801,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,2.4337378994,1.0459119952,5.6630769991,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.376745928,0.979105823,1.9358779263,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2325,4313,0.9429922051,0.8220812086,1.0816866868,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,8.9203526723,1.1676363243,68.14852377,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1936,705,1.102927805,0.7040187642,1.7278655127,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2325,1428,0.8985401375,0.7560279007,1.0679161151,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,2.4964598256,1.0718512976,5.8145301267,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.4036042906,1.0010729622,1.967993422,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2325,4313,0.9702338214,0.8459682842,1.1127529077,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,9.2302794224,1.2050307406,70.701979081,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1936,705,1.1380997943,0.7216874702,1.7947812528,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2325,1428,0.9734595399,0.8179866845,1.1584827647,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,2.4677586825,1.0595425344,5.7476058937,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.3646962309,0.9868195099,1.887270959,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.0065812258,0.8775172004,1.154627811,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,9.8848879418,1.2918464969,75.636702853,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1936,705,1.2083425748,0.7655817085,1.9071664877,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2325,1428,1.0542077204,0.8856707225,1.2548161405,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,2.4256525587,1.0419105508,5.6471165694,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.3470173706,0.9697758144,1.8710054115,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2325,4313,0.9796181661,0.853753369,1.1240386114,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,0.4320214515,0.1128692724,1.6536168839,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.5657633002,0.314101863,1.0190583041,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2325,1428,0.8712532669,0.6570999744,1.1552005548,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,3.8334486252,0.7972106661,18.433431696,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.8502913138,1.0870189707,3.1495107614,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2325,4313,1.3346822049,1.0644691435,1.673488235,1,1
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,0.3690876114,0.0904556686,1.5059936761,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.5756812481,0.2751664024,1.2043944918,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,2325,1428,0.9061685766,0.6500562016,1.2631853789,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,2.295189677,0.4331202841,12.162662075,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.3180341819,0.6362716784,2.7303024221,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2325,4313,1.497164097,1.1259099676,1.9908344343,1,1
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,0.3996709317,0.0972492951,1.6425502464,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1936,705,0.5985245179,0.2869303323,1.2484967889,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2325,1428,1.0119107506,0.7092810402,1.4436638076,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,2.2498991037,0.426401384,11.87155147,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.298183652,0.6243251234,2.699364051,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.4686083845,1.1062915777,1.9495860137,1,1
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,0.3706857234,0.090873075,1.5120860119,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1936,705,0.5978731312,0.2870211377,1.2453866078,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2325,1428,0.9470741752,0.6747986037,1.329210654,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,2.3298262214,0.4395498831,12.349201832,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.316049787,0.6352120046,2.7266283215,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.4951667432,1.1248930503,1.9873210074,1,1
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,0.3715469438,0.0910459533,1.5162357741,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1936,705,0.5793621366,0.2768217463,1.2125510002,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2325,1428,0.9232105648,0.6659698263,1.2798143598,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,2.2913244749,0.43237296,12.142683134,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.3076840966,0.6307661967,2.7110484131,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2325,4313,1.5052865148,1.1340306523,1.998083109,1,1
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,0.3988603956,0.0970914849,1.6385537342,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1936,705,0.616686125,0.2966711705,1.2818966405,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2325,1428,1.0572879483,0.742602721,1.5053241446,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,2.2823411063,0.432358855,12.048049591,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1936,2643,1.2929135917,0.6214380284,2.6899312227,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2325,4313,1.4710109826,1.111938653,1.9460365959,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,534,122,2.6506771052,0.3497134502,20.090989102,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1878,683,1.1928775262,0.5988538193,2.3761337854,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2209,1344,1.5018730215,0.9485852536,2.3778807061,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,636,1.1279821536,0.5228242176,2.4335975576,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1878,2609,1.2126725037,0.7946269511,1.8506477777,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2209,4211,1.108104043,0.8241179028,1.4899501225,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,534,122,3.7862483119,0.4823533801,29.720277435,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1878,683,1.2989912842,0.6060752638,2.7841069541,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,2209,1344,1.425159879,0.8642208469,2.3501870938,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,636,1.2210005993,0.5117422799,2.9132681082,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1878,2609,1.1607613191,0.6862327496,1.9634254425,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2209,4211,0.9580229866,0.6719160546,1.3659564117,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,122,3.8565087567,0.4895796839,30.378425168,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1878,683,1.3183400842,0.6145605619,2.8280704711,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2209,1344,1.4670567864,0.894976014,2.4048193258,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,636,1.2184574313,0.5099378349,2.9114107842,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1878,2609,1.1571958844,0.682884729,1.960949276,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2209,4211,0.9532112626,0.6656311263,1.3650378946,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,534,122,3.8090848582,0.4854686342,29.886848364,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1878,683,1.2599070058,0.5904517441,2.6883918614,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2209,1344,1.3825448035,0.84131014,2.2719684965,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,534,636,1.2106779924,0.5073436801,2.8890498864,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1878,2609,1.1648230865,0.688265294,1.9713515045,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2209,4211,0.9599278257,0.6731412946,1.3688974929,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,534,122,3.7440471475,0.4768433368,29.397263131,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1878,683,1.294731142,0.6043409416,2.77381295,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2209,1344,1.3732869201,0.8314117125,2.2683310044,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,534,636,1.2246736069,0.513271487,2.9220899296,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1878,2609,1.1727573722,0.6932508889,1.9839280066,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2209,4211,0.9437155338,0.6612348687,1.3468724213,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,534,122,3.8839743822,0.4926352356,30.621555083,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1878,683,1.2815170013,0.6000714182,2.7368172769,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2209,1344,1.3792933571,0.8422090155,2.2588812635,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,534,636,1.2077897395,0.5054559153,2.8860203444,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1878,2609,1.1720621836,0.6913825616,1.9869314596,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2209,4211,0.9384778018,0.6547094324,1.3452388813,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,545,126,91852.882021,33752.909736,249962.21072,0,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1910,700,1.0827222279,0.4895930653,2.3944118206,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2264,1375,1.1674764486,0.7169081458,1.9012216084,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,545,636,0.6333500807,0.1852394998,2.1654794208,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1910,2629,1.2619100966,0.7881928445,2.0203394424,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2264,4256,1.1796671886,0.8400933517,1.6565000461,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,545,126,22288.756253,7003.6331309,70932.992349,0,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1910,700,0.4259948272,0.1357553278,1.3367548493,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2264,1375,1.225314175,0.7122657305,2.1079138913,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,545,636,0.5261213924,0.1340165752,2.0654439139,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1910,2629,0.8306699064,0.4729267346,1.4590261936,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2264,4256,1.2261684019,0.8045700945,1.8686860972,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,545,126,40179.916652,12579.039103,128342.5299,0,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1910,700,0.4395376865,0.1370361452,1.4097986887,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2264,1375,1.4128085398,0.7700450455,2.592092478,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,545,636,0.52560314,0.1337533117,2.0654341742,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1910,2629,0.8259597097,0.4689778387,1.4546730907,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2264,4256,1.2101176293,0.7927330543,1.8472607758,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,545,126,22237.253189,6993.9417706,70703.395253,0,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1910,700,0.4344380225,0.138956783,1.3582380893,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2264,1375,1.2543640479,0.7250115708,2.1702124876,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,545,636,0.53069735,0.134941056,2.0871311189,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1910,2629,0.8295388839,0.4724165691,1.4566270636,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2264,4256,1.2253723911,0.8042076152,1.8671018134,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,545,126,22232.385553,6986.1178521,70751.593063,0,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1910,700,0.4246429286,0.1352866037,1.3328859762,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2264,1375,1.2147348594,0.706109372,2.0897340229,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,545,636,0.5265572025,0.1341248123,2.0671975812,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1910,2629,0.832928673,0.4740600187,1.4634648503,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2264,4256,1.222078389,0.8021907882,1.8617461218,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,545,126,39865.600811,12505.140985,127089.02122,0,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1910,700,0.4439962479,0.1392135035,1.4160455927,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2264,1375,1.4152994681,0.7732650928,2.5904086491,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,545,636,0.5311886403,0.1348732592,2.0920482923,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1910,2629,0.8302904083,0.4707378244,1.4644715729,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2264,4256,1.1981212901,0.788226985,1.8211690962,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,556,127,604263.39069,83775.820033,4358468.1736,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1936,705,320564.01519,78403.341643,1310674.8473,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2319,1423,1.4542366106,0.4647453791,4.5504575511,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,556,641,1.0979504213,0.0686311273,17.564845211,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.7686889669,0.1269295516,4.6552021996,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2319,4309,1.6660608372,0.7374126419,3.764186502,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,556,127,1170239.232,155615.19981,8800296.2556,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1936,705,112600.51881,27510.984312,460865.98331,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,2319,1423,1.7084061764,0.5185801611,5.6281591212,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,556,641,3.1870581224,0.1975966333,51.40441569,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.3478514207,0.0573183292,2.1110282264,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2319,4309,1.6800668393,0.6915185993,4.081776813,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,556,127,2706972.2955,368463.81014,19887160.712,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1936,705,271267.16877,65744.139904,1119276.592,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2319,1423,1.4963319603,0.4697536267,4.7663481627,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,556,641,3.2829982763,0.2026167372,53.194409458,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.3549979785,0.0585339638,2.1529989881,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2319,4309,1.7485646195,0.7056897279,4.332609797,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,556,127,1168913.4913,155589.14684,8781838.4369,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1936,705,117177.11522,28634.611252,479506.29434,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2319,1423,1.7894160383,0.5255371923,6.0928318769,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,556,641,3.2309768453,0.2022376786,51.618528497,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.3476597233,0.0572944743,2.1095801054,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2319,4309,1.6805502807,0.6915028399,4.0842193014,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,556,127,1212503.9357,160693.23283,9148896.7403,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1936,705,114861.77584,28032.497039,470640.46883,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2319,1423,1.7937597079,0.5414770894,5.9422161202,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,556,641,3.1751223772,0.1969066982,51.198878454,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.3409544948,0.056057657,2.073757161,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2319,4309,1.7097954271,0.700641618,4.1724618229,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,556,127,2778546.2702,372407.35046,20730845.85,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1936,705,288120.93104,69564.416506,1193335.2577,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2319,1423,1.6434762528,0.4965964778,5.4390522574,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,556,641,3.3308846296,0.2076927451,53.41925839,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1936,2643,0.3463614579,0.0568106424,2.1116863762,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2319,4309,1.815225379,0.716550614,4.5984793149,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,1323558.0686,321651.41173,5446287.1823,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.5695067025,0.0511892718,6.3360519269,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2321,1423,0.9865693272,0.3288573743,2.9596995946,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1320632.2161,325278.85366,5361767.0826,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,2.4827282955,0.2227926806,27.666706886,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2321,4310,2.2036520432,0.8609322988,5.6404926778,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,1521493.3238,336838.23185,6872562.8965,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1936,705,0.5775853633,0.0516007994,6.465110145,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,2321,1423,0.7450010355,0.2374814208,2.3371366947,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1513758.4166,342195.08754,6696368.9053,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2643,2.3403641741,0.2093719182,26.160645206,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2321,4310,1.7842051316,0.6569896262,4.8454158556,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,846239.04845,171552.86442,4174343.1656,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1936,705,0.6186562053,0.0560744946,6.8254828317,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2321,1423,0.8423149681,0.2568355207,2.7624469681,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,1067181.1365,247682.06227,4598135.0755,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1936,2643,2.290972785,0.2021141367,25.968279056,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2321,4310,1.7460345167,0.6404615732,4.7600615885,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,1569539.5337,344461.13227,7151617.7505,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1936,705,0.5221114797,0.0470954263,5.7882562827,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2321,1423,0.6615714558,0.2049609036,2.1354159911,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,1463753.1384,331271.20566,6467731.6151,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1936,2643,2.3574285481,0.2107704827,26.367398737,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2321,4310,1.7957561812,0.661572957,4.8743532034,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,1662986.2875,367852.83042,7518015.8033,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1936,705,0.5951594523,0.0530619276,6.675497667,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2321,1423,0.8077409306,0.266027108,2.4525523581,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,1688585.2614,381523.76703,7473506.0604,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1936,2643,2.2849730945,0.2039748359,25.596794919,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2321,4310,1.8346302498,0.6803673532,4.9471335412,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,1843134.5904,372682.05521,9115397.6181,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1936,705,0.6386739567,0.0558917122,7.2981200045,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2321,1423,0.8359225232,0.2563420505,2.725914314,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,2072250.4061,478928.59341,8966308.9754,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1936,2643,2.2602369136,0.2012710151,25.382049688,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2321,4310,1.8196821492,0.6737136947,4.914911409,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,1.0135530745,0.8106484048,1.2672446262,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1935,705,0.2697907063,0.0169276041,4.2999012117,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2317,1419,0.6329157958,0.3314482943,1.2085818858,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,0.9964309273,0.8780869272,1.1307247177,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1935,2643,961982.4956,136082.03323,6800385.7665,0,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2317,4304,1.9882419899,1.0623884228,3.7209613034,1,1
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,1.0404474786,0.799048295,1.3547753778,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1935,705,0.3847223323,0.0241376025,6.1319790661,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,2317,1419,0.7872025623,0.3616932778,1.7132966303,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1.0181605017,0.8648017157,1.1987150214,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1935,2643,224150.8887,31767.729082,1581593.0933,0,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2317,4304,2.4473703566,1.1274338815,5.3126145671,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,1.4562606112,1.0811932389,1.9614393537,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1935,705,0.4104761427,0.0259168873,6.501192137,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2317,1419,0.9292759734,0.4227032561,2.0429315892,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,1.620522258,1.3455126239,1.9517411743,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1935,2643,303107.09217,42741.049001,2149547.3665,0,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2317,4304,2.3673093452,1.0735331034,5.220289452,1,1
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,1.0368318248,0.7974985875,1.3479901404,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1935,705,0.3970188585,0.0249325944,6.3220045067,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2317,1419,0.8192252015,0.3753038073,1.7882310749,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,1.0302994871,0.87284277,1.2161606529,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1935,2643,223470.5332,31644.685791,1578118.9783,0,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2317,4304,2.4445992223,1.1264029144,5.3054420234,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,0.7748297171,0.5790466327,1.0368095703,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1935,705,0.4041521595,0.025265296,6.4649536781,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2317,1419,0.8986331443,0.3968157591,2.0350540758,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,1.1614598959,0.9849491796,1.3696027344,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1935,2643,380317.63736,53710.947715,2692961.3317,0,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2317,4304,2.5821059482,1.169969209,5.6986723036,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,1.4128280047,1.0527574093,1.8960521706,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1935,705,0.4491615149,0.0279010761,7.2307629307,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2317,1419,1.0773632401,0.4699049356,2.470098659,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,1.6131669246,1.3417205467,1.9395302046,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1935,2643,462184.89592,65224.719635,3275060.1185,0,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2317,4304,2.518210224,1.0989470849,5.7704168101,1,1
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,554,128,25274.955014,9316.3143291,68570.394729,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1928,699,1.3995763446,0.4088528235,4.7910001641,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2264,1372,1.0868812254,0.7799932264,1.5145141755,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,554,641,0.4850099805,0.149654723,1.5718493641,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1928,2635,0.8924565674,0.4667881697,1.7062958669,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2264,4239,0.9718183932,0.770714913,1.2253960231,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,554,128,23142.614979,7855.7871685,68176.570546,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1928,699,0.9527697265,0.2311786297,3.9267044408,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,2264,1372,1.0303004786,0.7173311165,1.4798174118,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,554,641,0.4390090512,0.123726012,1.5577075824,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1928,2635,0.7779520816,0.3488860141,1.7346910357,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2264,4239,0.9210024856,0.7001292385,1.2115557125,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,554,128,25844.879825,8760.3620919,76247.740235,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1928,699,1.0343298075,0.2503157624,4.2739543865,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2264,1372,1.1345592898,0.7852841088,1.639183536,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,554,641,0.4270923017,0.1201577606,1.5180695215,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1928,2635,0.7617753116,0.340782408,1.702850886,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2264,4239,0.8922782169,0.6761254428,1.1775335846,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,554,128,23167.206681,7861.6460368,68270.622064,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1928,699,0.9298850312,0.2250598235,3.8420281221,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2264,1372,1.0047686006,0.6986251636,1.4450666729,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,554,641,0.43596173,0.122923403,1.5461875074,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1928,2635,0.7781574948,0.3488838264,1.735618108,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2264,4239,0.9214061557,0.7004630583,1.2120400837,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,554,128,23281.993535,7903.7636314,68581.406058,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1928,699,0.9550224476,0.2317309677,3.9358911946,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2264,1372,1.0433465336,0.7247769464,1.5019406932,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,554,641,0.4384465588,0.1235647704,1.5557459001,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1928,2635,0.7752599889,0.3475697201,1.7292301822,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2264,4239,0.9257073416,0.7026966373,1.2194936433,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,554,128,26067.466486,8827.0379007,76980.84189,0,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1928,699,1.0159225431,0.2454646692,4.2046727826,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2264,1372,1.1138255784,0.7693611239,1.6125163862,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,554,641,0.4229111434,0.11904602,1.5023923961,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1928,2635,0.7620052795,0.340877365,1.7034045251,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2264,4239,0.8972047718,0.6793565647,1.1849100228,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,1.0176285923,0.0000107693,96158.835949,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1936,705,3002049.9994,430801.90019,20919833.908,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2323,1425,2.7657205159,0.3192230562,23.961959587,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1.0476194E-7,9.504653E-13,0.0115470441,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2642,2994073.2001,428468.3177,20922140.464,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2323,4308,1.6287155993,0.491111032,5.4014557416,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,1.0416522235,1.0416522235,1.0416522235,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1936,705,1118381.9492,159250.80239,7854140.5469,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,2323,1425,3.6835483243,0.3867667633,35.08193967,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,1.8451915E-7,2.889022E-8,1.1785066E-6,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1936,2642,1119116.3201,159347.56681,7859682.849,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2323,4308,2.0602052941,0.5095556916,8.3296996258,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,0.742264292,0.5981988198,0.9210253532,1,1
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1936,705,917130.30104,130858.15103,6427784.4558,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2323,1425,2.9842342604,0.3137243247,28.386877966,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,1.8678706E-7,2.6478392E-8,1.3176557E-6,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1936,2642,1190935.2222,169042.23333,8390368.9362,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2323,4308,2.1437145385,0.5302455887,8.6667614413,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,1.0418895484,0.9645719048,1.1254047788,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1936,705,1229983.9026,172983.06375,8745713.9899,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2323,1425,4.1310973227,0.4112489382,41.497894594,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,1.9279363E-7,2.719832E-8,1.3666058E-6,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1936,2642,1107021.8423,157726.70647,7769751.7862,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2323,4308,2.0514334578,0.5109279631,8.2367369485,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,1.0460067667,1.0460067667,1.0460067667,1,1
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1936,705,1124223.0353,160350.59963,7881962.6237,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2323,1425,3.7345521282,0.3910471185,35.665470827,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,1.8377818E-7,2.8392388E-8,1.1895589E-6,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1936,2642,1117218.4822,158653.51588,7867314.6959,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2323,4308,2.0699326475,0.5126205665,8.3582701232,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,0.7395075804,0.3417583696,1.6001699156,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1936,705,1023218.899,143788.23068,7281381.1696,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2323,1425,3.450774489,0.3444222903,34.573385372,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,1.9561907E-7,2.4089409E-8,1.588533E-6,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1936,2642,1192974.9102,167997.71387,8471479.1866,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2323,4308,2.218345633,0.5419493685,9.0802898461,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,557,128,0.9980393515,0.6923918446,1.4386110335,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1934,704,2.1012893119,0.2633085974,16.76898064,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2320,1425,1.1261003378,0.4310131464,2.9421422094,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,3.0276422E-6,4.1711924E-7,0.000021976,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1934,2643,1.0266056473,0.3980016823,2.648026885,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2320,4305,1.1056838928,0.5574969066,2.1929034157,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,557,128,1.005411319,0.7481870209,1.3510685057,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1934,704,1.056075171,0.1303024897,8.5592744191,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,2320,1425,1.4555559489,0.5117523291,4.1399774854,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,557,642,3.2592091E-6,4.5756421E-7,0.0000232152,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1934,2643,0.6836971102,0.2541036151,1.8395713823,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2320,4305,1.3924928148,0.6206672063,3.1241158219,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,557,128,0.9658131828,0.6808381773,1.3700687406,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1934,704,1.0827136819,0.1310753261,8.9434751157,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2320,1425,1.4893015662,0.5248898287,4.2256851509,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,557,642,3.2167579E-6,4.4830522E-7,0.0000230814,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1934,2643,0.6888898858,0.2564236987,1.850723147,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2320,4305,1.379845065,0.6082570724,3.1302100542,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,557,128,1.003880242,0.7527184832,1.3388478731,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1934,704,1.1078275431,0.1356287915,9.0488299079,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2320,1425,1.5459395082,0.5197592627,4.5981459773,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,557,642,3.3177586E-6,4.6700839E-7,0.0000235703,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1934,2643,0.6826170178,0.2536952354,1.8367155857,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2320,4305,1.3913483172,0.6207989517,3.1183205682,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,557,128,1.007851657,0.7552211788,1.3449900388,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1934,704,1.058779076,0.1306141925,8.582628812,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2320,1425,1.4692152128,0.5253872006,4.1085761877,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,557,642,3.2549405E-6,4.5736081E-7,0.0000231647,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1934,2643,0.6815420521,0.2529952088,1.8360014448,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2320,4305,1.3966940052,0.6258113305,3.1171601553,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,557,128,0.9609133748,0.6792581376,1.3593573088,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1934,704,1.1241933078,0.1359562785,9.2957133523,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2320,1425,1.5868802563,0.5445531306,4.6243218638,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,557,642,3.2854011E-6,4.5803657E-7,0.0000235655,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1934,2643,0.6875120494,0.2556340101,1.8490216457,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2320,4305,1.384898494,0.6115408354,3.136248191,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,555,127,334540.27078,145656.5073,768363.83659,0,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1930,703,193332.91439,111549.8187,335075.54043,0,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2284,1394,0.9651861764,0.6877412159,1.3545565303,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,555,641,1.0885737206,0.3498668495,3.3869820675,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1930,2640,0.7226558974,0.3623183971,1.4413608315,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2284,4238,0.8535981311,0.6689689903,1.089183176,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,555,127,245388.79873,97554.561692,617251.12078,0,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1930,703,316476.78493,154074.89983,650057.57272,0,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,2284,1394,1.0344091794,0.6971419097,1.5348415231,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,555,641,0.7894539834,0.2321629049,2.6844839492,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1930,2640,1.2232981348,0.5293259066,2.8271019948,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2284,4238,0.8923389702,0.6511988442,1.222773727,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,555,127,265736.3391,104842.70466,673540.44465,0,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1930,703,338939.89944,162897.79778,705229.02702,0,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2284,1394,1.0762373101,0.7276237894,1.591875863,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,555,641,0.785115833,0.2316007927,2.661505878,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1930,2640,1.213115823,0.5260877145,2.7973472094,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2284,4238,0.8767295228,0.6350337274,1.2104154834,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,555,127,245510.80434,97579.437517,617707.54761,0,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1930,703,314776.78614,152304.03386,650569.93293,0,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2284,1394,1.0282511897,0.6841469646,1.5454289266,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,555,641,0.7878411812,0.2316028539,2.6799917028,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1930,2640,1.2232211363,0.5292690542,2.8270497518,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2284,4238,0.8927886456,0.6521315141,1.2222558618,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,555,127,246540.82912,98018.942652,620108.50944,0,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1930,703,317714.67638,154672.27696,652622.54857,0,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2284,1394,1.046944851,0.7041582821,1.5566010496,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,555,641,0.7886153037,0.2319157824,2.6816376659,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1930,2640,1.2181706287,0.526671993,2.8175784937,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2284,4238,0.8953784867,0.6534124233,1.2269473397,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,555,127,266818.21865,105219.80685,676602.28563,0,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1930,703,337009.17701,161355.6427,703881.08831,0,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2284,1394,1.0792507205,0.7216939469,1.613955781,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,555,641,0.7826022695,0.2307604868,2.6541212515,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1930,2640,1.2094454436,0.5239465093,2.791808429,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2284,4238,0.8802218925,0.6385399585,1.2133783794,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,554,127,0.9522278988,0.2095626901,4.3268101349,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1925,701,1.1909033833,0.5259962069,2.6963138703,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2256,1369,0.6242380793,0.4698911181,0.8292839864,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,554,636,0.6279501585,0.2876728537,1.3707285776,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1925,2632,1.193521307,0.7292022887,1.9534951171,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2256,4206,0.7360102531,0.5874747983,0.9221009893,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,554,127,1.4616357242,0.268102004,7.9685304796,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1925,701,2.0415767451,0.8277522443,5.0353661195,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,2256,1369,0.6543425782,0.4616792227,0.9274062781,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,554,636,1.3902927064,0.4917206184,3.9309187721,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1925,2632,1.5166397839,0.8099762242,2.8398317943,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2256,4206,0.788024165,0.5839226136,1.0634664082,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,554,127,1.4505768264,0.2675498962,7.864600806,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1925,701,2.0271627574,0.8203065577,5.0095769761,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2256,1369,0.6551648518,0.4657860906,0.9215410071,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,554,636,1.3932227479,0.4918495703,3.9464701049,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1925,2632,1.5162419035,0.8098513084,2.8387797687,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2256,4206,0.7866803847,0.580218722,1.0666081673,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,554,127,1.4632840914,0.267566817,8.0024883362,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1925,701,2.1239110617,0.8609547313,5.2395300634,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2256,1369,0.6853077754,0.4784348016,0.9816316569,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,554,636,1.4095575449,0.4970371864,3.9973919998,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1925,2632,1.5158490518,0.809506656,2.8385169296,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2256,4206,0.7853142767,0.5828990272,1.0580194587,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,554,127,1.4740656394,0.270302298,8.0386645819,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1925,701,2.0659032285,0.8367191967,5.1008225536,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2256,1369,0.672870801,0.4749201764,0.9533288694,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,554,636,1.3866359967,0.4903835211,3.920929853,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1925,2632,1.5014904202,0.801724521,2.8120300962,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2256,4206,0.7954072572,0.5896213864,1.0730151912,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,554,127,1.4447914136,0.2654649686,7.8632681372,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1925,701,2.1127088516,0.8542792708,5.2249174761,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2256,1369,0.697325826,0.4912453319,0.9898583783,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,554,636,1.4131850556,0.4975302408,4.0140112853,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1925,2632,1.5047461877,0.8035970761,2.8176572024,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2256,4206,0.7936199534,0.5858559715,1.0750639423,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,550,125,77775.184879,43481.791736,139115.22827,0,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1897,689,1.2418151094,0.6656421212,2.3167175226,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2250,1366,1.3321527384,0.9135404195,1.9425860976,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,550,638,2.0530135255,0.8191004371,5.1457237052,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1897,2611,1.6590990148,1.1051931525,2.4906140024,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2250,4238,1.4213112549,1.0880182472,1.8567020255,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,550,125,52718.951314,26609.645293,104446.63193,0,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1897,689,0.9633894568,0.4465557383,2.0783950713,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2250,1366,1.2540578148,0.835797336,1.881629595,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,550,638,1.1459050917,0.4094242445,3.207183006,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1897,2611,1.4582912456,0.8784189792,2.4209556114,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2250,4238,1.2308202892,0.9032331204,1.6772177084,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,550,125,54753.445421,27512.230496,108967.5294,0,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1897,689,0.9886214451,0.4599074676,2.1251500149,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2250,1366,1.3066632643,0.8611445078,1.9826740701,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,550,638,1.1385958892,0.4066740591,3.1878123766,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1897,2611,1.4503170753,0.8728220966,2.4099064715,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2250,4238,1.2195523863,0.8940557796,1.6635517121,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,550,125,52767.387651,26619.126901,104601.37216,0,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1897,689,0.955486558,0.4419317143,2.065827215,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2250,1366,1.2425651069,0.8277033758,1.8653639578,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,550,638,1.1424185691,0.4082167438,3.1971255633,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1897,2611,1.4590637345,0.8785120929,2.4232642881,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2250,4238,1.2313417394,0.9036266944,1.6779080217,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,550,125,52448.236728,26464.09549,103945.26943,0,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1897,689,0.9543391497,0.4426603153,2.0574765373,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2250,1366,1.2215122679,0.8141939244,1.8326005341,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,550,638,1.1484979072,0.4103419406,3.2145079807,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1897,2611,1.4708347187,0.8860382535,2.4416042547,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2250,4238,1.2187812088,0.8946024815,1.6604331706,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,550,125,54874.675862,27509.356134,109462.03307,0,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1897,689,0.9739528014,0.4525730848,2.0959798346,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2250,1366,1.2663313995,0.8349702264,1.9205417903,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,550,638,1.1358471648,0.4057242381,3.1798661764,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1897,2611,1.462476319,0.8799120156,2.4307396029,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2250,4238,1.2062706265,0.8845981153,1.6449151307,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,123,1.8990481663,0.4456353203,8.0926797622,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1862,681,0.8652869911,0.5086550405,1.4719633491,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2225,1347,1.1537442606,0.7984279698,1.6671833518,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,635,2.3801646575,1.0802265395,5.2444404849,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1862,2599,2.0535476375,1.3414510022,3.1436540675,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2225,4217,1.9467469742,1.4594131246,2.596813553,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,123,3.2277568254,0.7135921038,14.599957131,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1862,681,0.7975772767,0.4367008071,1.4566712539,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2225,1347,1.1242619964,0.7335568276,1.723063557,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,635,2.5018670038,0.9604665324,6.5169772123,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1862,2599,2.3127234376,1.4369171897,3.7223367756,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2225,4217,1.7893714696,1.2485711876,2.5644114553,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,123,3.3455367648,0.7394947331,15.135491496,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1862,681,0.8245613371,0.4500794082,1.5106254277,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2225,1347,1.1903046549,0.7843457483,1.8063783409,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,635,2.4788453321,0.9507933716,6.4626809184,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1862,2599,2.2990092488,1.4304466143,3.6949603525,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2225,4217,1.7639223452,1.2227639998,2.5445809989,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,123,3.2401555707,0.7165198197,14.652222916,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1862,681,0.8278149994,0.4530575199,1.5125621871,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2225,1347,1.1782080077,0.7616776173,1.8225218623,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,635,2.5470915921,0.9791154332,6.626057928,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1862,2599,2.3032930069,1.431832609,3.7051528527,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2225,4217,1.7860696648,1.2473358271,2.5574867474,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,123,3.2072098896,0.7090320903,14.507376205,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1862,681,0.7917141557,0.4338079057,1.4449052131,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2225,1347,1.1023385724,0.7190083121,1.6900365513,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,635,2.5060113168,0.9620520187,6.5278099295,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1862,2599,2.3264200384,1.445424665,3.744387602,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2225,4217,1.7766660237,1.2397423745,2.5461275057,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,537,123,3.3166381069,0.7327676284,15.011700717,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1862,681,0.8426808975,0.4607628023,1.5411641122,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2225,1347,1.2121437456,0.7915552873,1.8562095203,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,537,635,2.5336773795,0.9728782286,6.5984836276,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1862,2599,2.3034314395,1.4340974775,3.6997459933,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2225,4217,1.7443959908,1.2094627366,2.5159248654,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,525,119,1.1616833526,0.345542083,3.9054814972,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1822,661,1.3756925724,0.8294055075,2.2817910377,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2181,1309,1.5102630128,1.0995861836,2.0743206871,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,525,619,0.5965420213,0.3365898043,1.0572583563,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1822,2544,0.9151901418,0.6956715978,1.203977564,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2181,4142,1.2669269327,1.0285808817,1.5605032927,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,525,119,1.0903942856,0.3071192189,3.8713295189,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1822,661,1.4057778067,0.7960598153,2.482490893,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2181,1309,1.2752688308,0.900918962,1.805168566,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,525,619,0.4932590953,0.2527347693,0.9626872303,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1822,2544,0.8825767211,0.6334909065,1.2296019732,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2181,4142,1.0337068386,0.8053223942,1.3268596973,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,525,119,1.1063837276,0.3103643035,3.9440262256,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1822,661,1.4149724037,0.8013741931,2.4983920377,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2181,1309,1.284844128,0.9082845969,1.8175189129,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,525,619,0.4935288608,0.2527667997,0.9636183898,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1822,2544,0.8838415851,0.6338164286,1.2324955811,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2181,4142,1.0305032049,0.8016975406,1.3246103444,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,525,119,1.0899754405,0.3073403207,3.8655730494,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1822,661,1.3637179922,0.7710418689,2.4119659866,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2181,1309,1.2283984969,0.8665173363,1.7414110531,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,525,619,0.4868560631,0.2490490695,0.9517354418,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1822,2544,0.8825700699,0.6333373085,1.229881641,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2181,4142,1.0343965793,0.8060657314,1.3274057457,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,525,119,1.0799741167,0.304169519,3.8345199634,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1822,661,1.3913359506,0.7887447608,2.4542993167,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2181,1309,1.23983527,0.8726316224,1.7615583223,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,525,619,0.4943346918,0.2532801128,0.9648084281,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1822,2544,0.8915338667,0.6400060518,1.2419142493,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2181,4142,1.0240321875,0.7965647438,1.3164553532,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,525,119,1.1106582231,0.3117384734,3.9570402558,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1822,661,1.3701213859,0.7756872134,2.4200896697,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2181,1309,1.2119709652,0.8532572938,1.721489674,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,525,619,0.4867250186,0.2489341053,0.9516624625,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1822,2544,0.8914056859,0.6393058997,1.2429168842,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2181,4142,1.0202096574,0.7926646011,1.3130745887,1,0
